LCM
LOXO

Laurion Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Laurion Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,006
Closed -$830K – 2008
2017
Q3 		$830K Buy
+9,006
New +$700K ﹤0.01% 1036

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Laurion Capital Management's LOXO Position: Q4 2017 in Review

Laurion Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 9,006 shares — an estimated $830K sold.

Laurion Capital Management first reported a position in LOXO in Q3 2017 and held it in 1 quarter. The position peaked at $830K in Q3 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • Laurion Capital Management reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
  • Laurion Capital Management sold 9,006 Loxo Oncology, Inc shares in Q4 2017, an estimated $830K.
  • Laurion Capital Management first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 1 quarter.
  • Laurion Capital Management's Loxo Oncology, Inc position peaked at $830K in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Laurion Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.